NOD1 and central nervous system cancer: WB results (Figure 5C,D) exhibited relative protein expression levels of NOD1, RIP2, Iba1, IL‐1β, and CD206 in glioma tissues in the Glioma group that were higher than in the Sham group (p < 0.05), with decreased expression following ML130 treatment.